NO20044945L - Tcelle reseptor CDR3 sekvenser og fremgangsmater for deteksjon - Google Patents

Tcelle reseptor CDR3 sekvenser og fremgangsmater for deteksjon

Info

Publication number
NO20044945L
NO20044945L NO20044945A NO20044945A NO20044945L NO 20044945 L NO20044945 L NO 20044945L NO 20044945 A NO20044945 A NO 20044945A NO 20044945 A NO20044945 A NO 20044945A NO 20044945 L NO20044945 L NO 20044945L
Authority
NO
Norway
Prior art keywords
methods
detection
cell receptor
cdr3 sequences
receptor cdr3
Prior art date
Application number
NO20044945A
Other languages
English (en)
Norwegian (no)
Inventor
Jingwu Z Zhang
Original Assignee
Opexa Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opexa Pharmaceuticals Inc filed Critical Opexa Pharmaceuticals Inc
Publication of NO20044945L publication Critical patent/NO20044945L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
NO20044945A 2002-06-05 2004-11-12 Tcelle reseptor CDR3 sekvenser og fremgangsmater for deteksjon NO20044945L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38628702P 2002-06-05 2002-06-05
PCT/US2003/017873 WO2003104407A2 (fr) 2002-06-05 2003-06-05 Sequences cdr3 des recepteurs des lymphocytes t et procedes de detection associes

Publications (1)

Publication Number Publication Date
NO20044945L true NO20044945L (no) 2004-12-28

Family

ID=29736145

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044945A NO20044945L (no) 2002-06-05 2004-11-12 Tcelle reseptor CDR3 sekvenser og fremgangsmater for deteksjon

Country Status (16)

Country Link
EP (1) EP1530483B1 (fr)
JP (3) JP2005528910A (fr)
CN (1) CN1674931A (fr)
AT (1) ATE453727T1 (fr)
AU (1) AU2003237437B2 (fr)
BR (1) BR0311578A (fr)
CA (1) CA2485874A1 (fr)
DE (1) DE60330780D1 (fr)
IL (2) IL165194A (fr)
MX (1) MXPA04011646A (fr)
NO (1) NO20044945L (fr)
NZ (1) NZ537403A (fr)
PL (1) PL213315B1 (fr)
RU (1) RU2004139045A (fr)
WO (1) WO2003104407A2 (fr)
ZA (1) ZA200409792B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
CA2880456A1 (fr) 2012-08-15 2014-02-20 Tris Pharma, Inc. Comprime a croquer de methylphenidate a liberation modifiee
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
CN108070644B (zh) * 2016-11-08 2021-06-29 国家卫生计生委科学技术研究所 一种妊娠高血压的诊断系统
JP7150280B2 (ja) 2017-03-15 2022-10-11 学校法人兵庫医科大学 がん免疫療法の新規バイオマーカ
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL165071A (en) * 1990-03-30 2008-06-05 Autoimmune Inc A peptide with the ability to stimulate a subset of T cells from multiple sclerosis patients
CA2362099C (fr) * 1999-02-23 2014-05-13 Baylor College Of Medicine Sequence v.beta.-d.beta.-j.beta. du recepteur de leucocytes t et procedes de sa detection

Also Published As

Publication number Publication date
AU2003237437B2 (en) 2010-11-25
JP2005528910A (ja) 2005-09-29
IL165194A0 (en) 2005-12-18
JP2013126420A (ja) 2013-06-27
CN1674931A (zh) 2005-09-28
IL206650A (en) 2016-10-31
IL206650A0 (en) 2011-07-31
IL165194A (en) 2010-11-30
RU2004139045A (ru) 2005-09-10
WO2003104407A2 (fr) 2003-12-18
MXPA04011646A (es) 2005-03-07
CA2485874A1 (fr) 2003-12-18
DE60330780D1 (de) 2010-02-11
PL213315B1 (pl) 2013-02-28
WO2003104407A3 (fr) 2005-03-24
EP1530483A4 (fr) 2006-05-17
EP1530483B1 (fr) 2009-12-30
EP1530483A2 (fr) 2005-05-18
JP2010207226A (ja) 2010-09-24
NZ537403A (en) 2009-10-30
BR0311578A (pt) 2007-04-27
PL374723A1 (en) 2005-10-31
AU2003237437A1 (en) 2003-12-22
ZA200409792B (en) 2006-07-26
ATE453727T1 (de) 2010-01-15

Similar Documents

Publication Publication Date Title
Graham et al. Pathway paradigms revealed from the genetics of inflammatory bowel disease
IL206650A0 (en) T cell receptor cdr3 peptide for treating an autoimmune disease
Villani et al. Systems immunology: learning the rules of the immune system
WO2005005651A3 (fr) Sequence de recepteur de lymphocyte t et methode destinee a la detection et au traitement de la polyarthrite rhumatoide
CY1107944T1 (el) Χρησεις του μπορρελιοκτονου επιτοπου (-ων) της πρωτεϊνης c εξωτερικης επιφανειας borrelia burgdorferi (ospc) σαν εμβολιο
DE60203692D1 (de) Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen
US20210033608A1 (en) Methods and Systems for Identification of Human Leukocyte Antigen Peptide Presentation and Applications Thereof
EP1021464A4 (fr) Recepteur cellulaire de la proteine virale (vpr) du vih-1 essentielle pour la transition de phase g2/m du cycle cellulaire
Zeng et al. Leveraging artificial intelligence for neoantigen prediction
DE69831500T2 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
Townsend et al. Innovations and trends in antibody repertoire analysis
WO2003072598A3 (fr) Peptides derives de hsp70 et utilisations de ceux-ci dans le diagnostic et le traitement de maladies auto-immunes
ATE534669T1 (de) Verfahren zum erhalten von anti-idiotyp antikörpern
ATE316577T1 (de) Das goodpasture-antigen bindende protein
EP2192407A3 (fr) Procédé de détection d'immunité cellulaire et application associée aux médicaments
AU2002341090A1 (en) Use of a protein of the crmp family for treating diseases related to the immune system
WO2004039334A3 (fr) Recepteur 2 detecteur de calcium (car2) et methodes faisant appel audit recepteur
DK1523548T3 (da) Polynukleotidsekvenser, som koder for alkaliske alfa-galactosidaser, og fremgangsmåder til anvendelse heraf
DE60127663D1 (de) Cng3b: neuartiger, zyklischer nukleotid-abhängiger kationenkanal
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
EP1796707A4 (fr) Peptides ciblant selectivement le systeme cardio-vasculaire et conjugues et procedes associes
AU2003302440A8 (en) Nucleic acid probes and method for detecting a target nucleic acid sequence comprise two or more cis- located nucleic acid regions
DK1512004T3 (da) Fremgangsmåde til kortlægning og eliminering af T-celleepitoper
DK1569961T3 (da) Splice variant af det menneskelige hypofysevæksthormon
WO2004009633A8 (fr) Recepteur de serotonine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application